"FAIR BALANCE" IN COMPARATIVE DRUG ADS REQUIRES MENTIONING ADVANTAGES OF COMPETITORS's DRUG AS WELL AS PROMOTED PRODUCT, FDA's BANKS TELLS RAPS MEETING

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".